AnaptysBio, Inc. (AN6)
FSX
Real-time Data
06:00 AM
Day's Range
46.7752 wk Range
16.70Overview - AN6 - AnaptysBio, Inc.
Key Statistics
Valuation
Enterprise Value
1.19B
P/E (Trailing)
‪-103.50‬
P/E (Forward)
‪-14.37‬
PEG Ratio
‪-2.36‬
Price / Sales (TTM)
‪6.10‬
Price / Book
‪125.83‬
EV / EBITDA
‪33.25‬
Profitability
Profit Margin
‪-11.52%‬
Operating Margin
‪-135.53%‬
Return on Assets
‪6.78%‬
Return on Equity
‪-114.55%‬
Ownership
Shares Outstanding
29.03M
Float
19.79M
Held by Insiders
‪5.67%‬
Held by Institutions
‪106.42%‬
Price stats
Beta
‪0.40‬
50-Day Avg
‪48.97‬
200-Day Avg
‪47.84‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - AN6 - AnaptysBio, Inc.
Peers - AN6 - AnaptysBio, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- AN6FSXAnaptysBio, Inc.1.39BMarket Cap+61.51%52-week change-103.50P/E (Trailing)‪-11.52%‬Profit Margin
- ANLFSXAnalog Devices Inc.151.88BMarket Cap+35.24%52-week change43.41P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE52.93BMarket Cap+23.73%52-week change38.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt51.30BMarket Cap+24.85%52-week change36.06P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna Inc.50.90BMarket Cap+83.96%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.38.16BMarket Cap+25.45%52-week change136.57P/E (Trailing)‪30.74%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.64BMarket Cap+77.80%52-week change-29.52P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - AN6 - AnaptysBio, Inc.
About
AnaptysBio, Inc. is a biotechnology company focused on immunology therapeutics for autoimmune and inflammatory diseases. AnaptysBio develops and manages antibody-based programs designed to modulate immune pathways involved in chronic immune dysfunction, with current work spanning clinical and preclinical candidates as…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
